P. Friberger

1.9k total citations
42 papers, 1.6k citations indexed

About

P. Friberger is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, P. Friberger has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Genetics and 11 papers in Cancer Research. Recurrent topics in P. Friberger's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Protease and Inhibitor Mechanisms (11 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). P. Friberger is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Protease and Inhibitor Mechanisms (11 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). P. Friberger collaborates with scholars based in Sweden, Germany and United States. P. Friberger's co-authors include Göran Claeson, Märta Knös, Erika Gyzander, A.‐C. Teger‐Nilsson, Leif Aurell, Stig Gustavsson, Egil Amundsen, J. Pütter, Göran Karlsson and E. Eriksson and has published in prestigious journals such as Thrombosis and Haemostasis, Advances in experimental medicine and biology and Thrombosis Research.

In The Last Decade

P. Friberger

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Friberger Sweden 18 606 383 370 309 286 42 1.6k
Ian MacGregor United Kingdom 26 781 1.3× 431 1.1× 138 0.4× 366 1.2× 712 2.5× 88 2.2k
VW van Hinsbergh Netherlands 14 707 1.2× 249 0.7× 125 0.3× 436 1.4× 325 1.1× 22 1.8k
G. Wijngaards Netherlands 24 940 1.6× 638 1.7× 134 0.4× 1.0k 3.3× 434 1.5× 57 2.3k
Y T Wachtfogel United States 17 498 0.8× 176 0.5× 418 1.1× 107 0.3× 171 0.6× 22 1.4k
Marion I. Barnhart United States 22 403 0.7× 388 1.0× 105 0.3× 120 0.4× 170 0.6× 76 1.3k
F De Cock Belgium 27 1.1k 1.7× 719 1.9× 122 0.3× 1.1k 3.5× 567 2.0× 55 2.3k
Cristina Lupu United States 22 593 1.0× 198 0.5× 201 0.5× 141 0.5× 340 1.2× 49 1.5k
S. Müllertz Denmark 22 809 1.3× 542 1.4× 188 0.5× 1.1k 3.7× 778 2.7× 42 2.9k
M Kopeć Poland 17 402 0.7× 480 1.3× 72 0.2× 122 0.4× 125 0.4× 77 1.0k
Taisuke Kanaji Japan 21 785 1.3× 487 1.3× 209 0.6× 95 0.3× 370 1.3× 55 2.1k

Countries citing papers authored by P. Friberger

Since Specialization
Citations

This map shows the geographic impact of P. Friberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Friberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Friberger more than expected).

Fields of papers citing papers by P. Friberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Friberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Friberger. The network helps show where P. Friberger may publish in the future.

Co-authorship network of co-authors of P. Friberger

This figure shows the co-authorship network connecting the top 25 collaborators of P. Friberger. A scholar is included among the top collaborators of P. Friberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Friberger. P. Friberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svensson, Maria, et al.. (1996). Activation of FXII during haemodialysis. Scandinavian Journal of Clinical and Laboratory Investigation. 56(7). 649–652. 25 indexed citations
2.
Friberger, P., et al.. (1994). Coacute Heparin: A New Simple Monotest for Monitoring Heparin Treatment. Seminars in Thrombosis and Hemostasis. 20(4). 328–332. 3 indexed citations
3.
Friberger, P., et al.. (1992). Two routine methods for antithrombin III determination. Thrombosis Research. 67(4). 473–478. 2 indexed citations
4.
Gallimore, M. J. & P. Friberger. (1991). Chromogenic peptide substrate assays and their clinical applications. Blood Reviews. 5(2). 117–127. 17 indexed citations
5.
Friberger, P.. (1983). Synthetic Peptide Substrate Assays in Coagulation and Fibrinolysis and Their Application on Automates. Seminars in Thrombosis and Hemostasis. 9(4). 275–294. 24 indexed citations
6.
Friberger, P. & Märta Knös. (1982). 13. Plasminogen determination in human plasma. Scandinavian Journal of Clinical and Laboratory Investigation. 42(sup162). 128–140. 4 indexed citations
7.
Gallimore, M. J. & P. Friberger. (1982). Brief Communication: Simple Chromogenic Peptide Substrate Assays for Determining Prekallikrein, Kallikrein Inhibition and Kallikrein “Like” Activity in Human Plasma. Scandinavian Journal of Clinical and Laboratory Investigation. 42(sup162). 293–298. 8 indexed citations
8.
Teger‐Nilsson, A.‐C., P. Friberger, & Erika Gyzander. (1982). Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scandinavian Journal of Clinical and Laboratory Investigation. 42(sup162). 403–409. 4 indexed citations
9.
Friberger, P., Märta Knös, Stig Gustavsson, Leif Aurell, & Göran Claeson. (1982). 12. A new specific substrate for the determination of plasmin activity. Scandinavian Journal of Clinical and Laboratory Investigation. 42(sup162). 121–127. 14 indexed citations
10.
Eriksson, E., S. Rosén, Märta Knös, & P. Friberger. (1981). Chromogenic Substrate Methods For The Determination Of FVIIIc, Endotoxin And Plasminogen Activator. Thrombosis and Haemostasis. 2 indexed citations
11.
Friberger, P., Märta Knös, & Mats Andersson. (1981). Antithrombin Assay - A Study Of Reaction Conditions, Reagents And Kinetics. Thrombosis and Haemostasis. 3 indexed citations
12.
Friberger, P., et al.. (1979). A Chromogenic Factor X Assay With New Standardized Reagents. Thrombosis and Haemostasis. 3 indexed citations
13.
Friberger, P., E. Eriksson, Stig Gustavsson, & Göran Claeson. (1979). Determination of Prekallikrein in Plasma by Means of a Chromogenic Tripeptide Substrate for Plasma Kallikrein. Advances in experimental medicine and biology. 120A. 67–82. 14 indexed citations
14.
Friberger, P., Märta Knös, Stig Gustavsson, Leif Aurell, & Göran Claeson. (1977). Methods for the Determination of Plasmin, Antiplasmin and Plasminogen by Means of the Substrate S-2251. Thrombosis and Haemostasis. 57 indexed citations
15.
Aurell, Leif, P. Friberger, Göran Karlsson, & Göran Claeson. (1977). A new sensitive and highly specific chromogenic peptide substrate for Factor Xa. Thrombosis Research. 11(5). 595–609. 108 indexed citations
16.
Teger‐Nilsson, A.‐C., P. Friberger, & Erika Gyzander. (1977). Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scandinavian Journal of Clinical and Laboratory Investigation. 37(5). 403–409. 181 indexed citations
17.
Friberger, P., et al.. (1976). Effects of Four Local Anaesthetics on the Membrane Stability of Isolated Rat Liver Lysosomes. Acta Pharmacologica et Toxicologica. 38(1). 24–30. 2 indexed citations
18.
Friberger, P., et al.. (1975). Proceedings: Determination of plasminogen by means of a chromogenic peptide substrate.. PubMed. 34(1). 321–321. 5 indexed citations
19.
Friberger, P.. (1974). Fluoride uptake from prophylactic dentifrices. IV. In vitro fluoride uptake from two different types of abrasive dentifrices.. PubMed. 67(4). 199–206. 1 indexed citations
20.
Friberger, P.. (1973). Fluoride uptake from prophylactic dentifrices. I. Methods for measuring fluoride uptake in tooth enamel in vitro and in vivo.. PubMed. 66(4). 365–75. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026